Login / Signup
Moshe Rogosnitzky
ORCID
Publication Activity (10 Years)
Years Active: 2020-2022
Publications (10 Years): 4
Top Topics
Alcohol Use Disorder
Lps Induced
Primary Care
Coronavirus Disease
Top Venues
JMIR public health and surveillance
Pharmacological reports : PR
JMIRx med
Pain management
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Samuel J Martin
,
Heath B McAnally
,
Paul Okediji
,
Moshe Rogosnitzky
Low-dose naltrexone, an opioid-receptor antagonist, is a broad-spectrum analgesic: a retrospective cohort study.
Pain management
12 (6) (2022)
Moshe Rogosnitzky
,
Esther Berkowitz
,
Alejandro Alex R Jadad
Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point.
JMIR public health and surveillance
6 (2) (2020)
Moshe Rogosnitzky
,
Paul Okediji
,
Igor Koman
Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19.
Pharmacological reports : PR
72 (6) (2020)
Moshe Rogosnitzky
,
Esther Berkowitz
,
Alejandro Alex R Jadad
No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19.
JMIRx med
1 (1) (2020)